Shilpa Medicare logo

Shilpa Medicare financials and balance sheet

NSE: SHILPAMEDBSE: 530549Pharmaceuticals & BiotechnologySmall Cap

Last close ₹864.30up ₹3.50 (0.41%)BSE ₹862.80

Share price at the NSE close on 23 Oct 2026. Previous close ₹860.80.

52-week range of traded prices to 23 Oct 2026
₹259.50Low, 27 Jan 2026₹1,095.00High, 1 Oct 2026
Market cap
₹16,904 Cr637th largest listed
P/E
56.9
P/E without one-offs
63.4
P/B
6.5
Dividend yield
0.07%
ROE
12.0%
ROE without one-offs
10.8%
ROCE
10.9%
Debt to equity
0.25
Volume, NSE
9,55,72541.8% delivered

10 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Shilpa Medicare annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
A loss in 1 of the 8 years with results on record

Operating and net margin, per cent

  • Operating margin
  • Net margin

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 0.2% of operating profit in the first full year.

The years either side of a change of basis do not compare. From the year to Mar 2018, GST replaced excise duty on 1 Jul 2017, and revenue before that day includes the duty.

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue1,539
  2. Materials and goods−460
  3. Employee costs−335
  4. Other expenses−309
  5. Operating profit435
  6. Depreciation−120
  7. Other income+9.8
  8. One-off items+29
  9. Finance costs−59
  10. Profit before tax295
  11. Tax−52
  12. Net profit243

What the company owns

  • Plant, investments and other assets₹2,775 Cr
  • Receivables₹519 Cr
  • Inventory₹367 Cr
  • Cash and bank₹45 Cr

What pays for it: net worth and liabilities

  • Net worth₹2,591 Cr
  • Borrowings₹658 Cr
  • Other liabilities₹314 Cr
  • Owed to suppliers₹142 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Shilpa Medicare quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 2 JunMar 2020Filed 18 JunMar 2021Filed 1 JunMar 2022Filed 24 MayMar 2023Filed 26 MayMar 2024Filed 25 MayMar 2025Filed 6 NovMar 2026Filed 22 May
Revenue from operations7847927339089011,1461,0501,1521,2861,539
6086295786887199429489079691,104
Materials and goods bought372356257278271383416408410460
Employee costs––176197235264287281293335
Other expenses––145214213294245218266309
Operating profit before depreciation175162156220182204102244317435
Operating margin22.4%20.5%21.2%24.2%20.2%17.8%9.7%21.2%24.6%28.2%
Materials, % of revenue––35.0%30.6%30.0%33.5%39.6%35.4%31.9%29.9%
Employee costs, % of revenue––24.1%21.7%26.1%23.1%27.4%24.4%22.8%21.8%
Other expenses, % of revenue––19.7%23.5%23.7%25.7%23.3%18.9%20.7%20.1%
Depreciation and amortisation30374244548095108113120
Operating profit after depreciation1451251141761281247137204315
Other income1822141730141782310
Finance costs3345224159927659
Profit before one-off items and tax16114412418813697−3453152266
One-off items−10020059506−2829
Profit before tax151144144188195102−3459124295
453426334942−7224452
Share of profit of joint ventures and associates–−7−82––−5−5−1–
Profit from discontinued businesses––––20––––
109105110–148–−323278243
Other comprehensive income––0–0–3−2−20
Total comprehensive income––110–148–−293076243
Net margin13.9%13.3%14.9%–16.4%–−3.1%2.8%6.1%15.8%
Net margin without joint ventures and associates–14.2%16.0%–––−2.6%3.2%6.2%–
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2017 and Mar 2018 they do not, so they are left blank. Net profit, net margin and net margin without joint ventures and associates are left blank for the years to Mar 2020 and Mar 2022: the profit stated for the year is its quarters' profit belonging to the company's shareholders added up, which leaves out the other owners' share those quarters state, so the group's profit is not stated. Share of profit of joint ventures and associates is left blank for the years to Mar 2021 and Mar 2026: the filing states 0 for this share both for the period and for the year so far, which the form also writes for a line it does not fill, while the company's other filings for the same year show it was not 0 over those months. Belonging to the company's shareholders is left blank for the year to Mar 2023: the filing's earnings per share does not match the profit it states, and cannot be multiplied back into the owners' profit because the company's periods around it state no share for other owners for the gap to belong to. Belonging to outside owners of subsidiaries is left blank for the year to Mar 2024: the filing states 0 for this share both for the period and for the year so far, which the form also writes for a line it does not fill, while the company's other filings for the same year show it was not 0 over those months.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Filed 2 JunMar 2020Filed 18 JunMar 2021Filed 1 JunMar 2022Filed 24 MayMar 2023Filed 26 MayMar 2024Filed 25 MayMar 2025Filed 6 NovMar 2026Filed 22 May
1,1901,3211,4671,8111,7741,8002,3642,591
1,1981,3291,4791,8221,7831,8092,3722,591
Share capital8889991020
Reserves1,1891,3211,4711,8141,7751,8002,3622,572
Belonging to outside owners of subsidiaries−8−8−11−11−9−9−9–
168330724682796936586658
254408542612783693674848
167257568453345600273266
Liabilities going with businesses held for sale––60–––––
1,6101,9862,6382,8752,9023,0933,3113,706
1,0651,3651,7201,9882,1342,2162,3252,596
5456218348877688779861,110
Net debt73286601648774905558613
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Filed 1 JunMar 2022Filed 24 MayMar 2023Filed 26 MayMar 2024Filed 25 MayMar 2025Filed 6 NovMar 2026Filed 22 May
47105226135132342
95140259176196403
−114−78149−84−83−35
Receivables13−16865−76−55−67
Inventories−106−3835−25−22−37
Payables−684−234−6935
Other working capital−144551−176434
Tax paid−48−34−32−41−47−60
Capital spending354332273185244371
Free cash flow−307−227−46−49−112−28
−404−285−278−167−199−326
4368346476314
Dividends paid09100010
Shares bought back000000
Shares issued0297004890
Net change in cash79−98−716−430
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.Shilpa Medicare dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 2 JunMar 2020Filed 18 JunMar 2021Filed 1 JunMar 2022Filed 24 MayMar 2023Filed 26 MayMar 2024Filed 25 MayMar 2025Filed 6 NovMar 2026Filed 22 May
₹6.88₹6.60₹6.89₹9.58₹9.07₹3.63₹1.87₹1.84₹4.02₹12.44
As stated that year₹13.76₹13.20₹13.77₹19.15₹18.13₹7.26₹3.74₹3.67₹8.04₹12.44
₹6.88₹6.60₹6.89₹9.58₹9.07₹3.63₹1.87₹1.84₹4.02₹12.44
₹0.30₹0.35₹0.50₹0.55₹0.55₹0.55––₹0.50₹0.60
––₹73.45₹81.53₹90.69₹104.96₹102.72₹104.19₹121.29₹132.47
Dividend payout4.4%5.4%7.3%5.7%6.1%15.7%––12.5%4.8%
Shareholder yield––––0.0%−8.3%0.5%0.0%−7.5%0.1%
Market cap at the year end (₹ crore)5,1083,7802,7801,9952,7213,4561,9863,9986,4876,824
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.

Ratios

Consolidated, years to March.Shilpa Medicare PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Filed 2 JunMar 2020Filed 18 JunMar 2021Filed 1 JunMar 2022Filed 24 MayMar 2023Filed 26 MayMar 2024Filed 25 MayMar 2025Filed 6 NovMar 2026Filed 22 May
Revenue growth–––23.8%−0.7%27.1%−8.3%9.7%11.7%19.6%
Operating profit growth–−7.6%−3.9%41.1%−17.4%12.2%−49.8%139.0%29.7%37.1%
Net profit growth–−3.5%4.0%–––––145.6%210.8%
Earnings per share growth–−4.1%4.3%39.1%−5.3%−60.0%−48.5%−1.9%119.1%209.5%
––9.4%12.4%10.5%3.7%–1.8%3.7%9.8%
–––3.0 pts−1.8 pts−6.9 pts––2.0 pts6.1 pts
From the net margin–––1.2 pts−0.6 pts−7.1 pts––2.1 pts6.0 pts
From asset turnover–––1.1 pts−2.7 pts0.2 pts––0.2 pts0.9 pts
From borrowing–––0.7 pts1.4 pts0.1 pts––−0.3 pts−0.8 pts
Return on capital employed––8.4%10.7%5.8%5.0%0.3%5.0%6.9%9.7%
Cash conversion––––31.9%––424.6%168.8%140.6%
Interest cover54.047.031.038.65.83.00.11.52.75.4
Debt to equity––0.140.250.490.380.450.520.250.25
Receivable days––1019890123113124125123
Inventory days––267298427338281309309291
Payable days––1181189713912715785113
Cash conversion cycle, days––251278420322267277350301
Working capital days––141134167182164167181164
Asset turnover––0.460.500.390.420.360.380.400.44
Assets per rupee of net worth––1.341.421.651.671.601.671.531.41
Sales per rupee of plant––1.481.630.930.970.910.991.081.16
Capital spending to depreciation––––6.564.162.851.712.163.10
Plant being built, % of plant in use––61.6%86.5%31.3%16.1%31.1%34.6%39.0%32.6%
Revenue growth is left blank for the years to Mar 2018 and Mar 2019: between the two periods excise duty was taken out of revenue when GST replaced it, so the two are on different bases and the change is not worked out. Cash conversion is left blank for the years to Mar 2020 and Mar 2022: the profit stated for the year is its quarters' profit belonging to the company's shareholders added up, which leaves out the other owners' share those quarters state, so the group's profit is not stated. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
6.9%
Cash from operations against operating profit
78.7%
Measure10 years5 years3 years
Revenue growth, yearly rate–11.3%13.6%
Profit growth, yearly rate–10.5%–
Return on equity, average–4.8%5.1%
Return on capital employed, average–5.4%7.2%
Operating margin, average21.0%20.3%24.7%
Net margin, average–5.4%8.2%
Asset turnover, average–0.400.41
Cash conversion cycle, days, average–303309
Interest cover, average18.92.53.2
Debt to equity, average–0.370.34

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations941610342
Cash from investing−1,256−692−326
Cash from financing25212314
Capital spending1,403799371
Dividends paid281010
Shares bought back000
Shares issued for cash7864890
Borrowings raised––105
Borrowings repaid333333

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––544887
Altman Z-scorePublished threshold 1.81––5.983.642.923.512.303.275.815.46
Beneish M-scorePublished threshold −1.78––––−2.55−2.00−3.00−2.46−2.38−2.48
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––21.848.740.692.114.546.47
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––2.157.776.351.72
Receivables growth less revenue growthOur threshold 0 percentage points–––−4.17−7.8846.36−7.7111.210.74−1.93
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––12.4142.44−29.43−18.509.860.18−6.77
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––5.237.14−5.14−0.880.624.580.69
Assets under construction, years of additionsOur threshold 2 years of additions–––4.520.650.645.553.293.471.67
Effective tax ratePublished threshold 17.16 per cent29.5823.5518.2217.8125.0440.76–37.8735.6317.60
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––7.04–−31.74−2.46−2.85
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
6 Jul 2026India Ratings and Research Private Limited (opens in a new tab)Bank loan facilitiesIND AA-; IND A1+Review, UpgradeStable110
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.